These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8455260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transmembrane oxalate exchange: its relationship to idiopathic calcium oxalate nephrolithiasis.
    Motola JA, Urivetsky M, Molia L, Smith AD.
    J Urol; 1992 Mar; 147(3):549-52. PubMed ID: 1538426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
    Gambaro G, Petrarulo M, Nardelotto A, Marangella M, Baggio B.
    Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
    [Abstract] [Full Text] [Related]

  • 6. Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalate nephrolithiasis.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A.
    Lancet; 1984 Jul 07; 2(8393):12-3. PubMed ID: 6145933
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Red blood cell transmembrane oxalate flux in calcium-oxalate nephrolithiasis.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A.
    Contrib Nephrol; 1985 Jul 07; 49():118-21. PubMed ID: 3830561
    [No Abstract] [Full Text] [Related]

  • 9. Nephrolithiasis and nephrocalcinosis with calcium oxalate crystals in the kidneys and other organs; report of two cases.
    LUND T, RESKE-NIELSEN E.
    Acta Pathol Microbiol Scand; 1956 Jul 07; 38(5):353-63. PubMed ID: 13339329
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
    Baggio B, Gambaro G, Zambon S, Marchini F, Bassi A, Bordin L, Clari G, Manzato E.
    J Am Soc Nephrol; 1996 Apr 07; 7(4):613-20. PubMed ID: 8724896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperoxaluria in idiopathic calcium oxalate nephrolithiasis.
    Yendt ER.
    Md Med J; 1988 Nov 07; 37(11):857-60. PubMed ID: 3185157
    [No Abstract] [Full Text] [Related]

  • 15. Clinical review 32: Calcium oxalate nephrolithiasis.
    Menon M, Koul H.
    J Clin Endocrinol Metab; 1992 Apr 07; 74(4):703-7. PubMed ID: 1548330
    [No Abstract] [Full Text] [Related]

  • 16. Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: clinical implications in calcium oxalate nephrolithiasis.
    Baggio B, Priante G, Brunati AM, Clari G, Bordin L.
    J Am Soc Nephrol; 1999 Nov 07; 10 Suppl 14():S381-4. PubMed ID: 10541268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Calcium oxalate nephrolithiasis: defective oxalate transport.
    Borsatti A.
    Kidney Int; 1991 Jun 07; 39(6):1283-98. PubMed ID: 1895680
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. No contribution of ascorbic acid to renal calcium oxalate stones.
    Gerster H.
    Ann Nutr Metab; 1997 Jun 07; 41(5):269-82. PubMed ID: 9429689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.